InvestorsHub Logo
icon url

I Like Bottom Fishing

11/18/09 9:14 AM

#1671962 RE: $heff #1671954

PWRM News Is Power3 Medical (OTCBB: PWRM) the Next "Vermillion Dollar Baby?"

Wednesday, November 18, 2009 6:51 AM

Scottrade.com
This email is compliments of Scottrade.com

News for 'PWRM' - (Is Power3 Medical (OTCBB: PWRM) the Next "Vermillion Dollar Baby?")

LOS ANGELES, CA, Nov 18, 2009 (MARKETWIRE via COMTEX) -- BioMedReports.com, the
news portal which covers Wall Street's biomedical sector and delivers financial
and investment intelligence to a community of highly informed investors, has
issued a special report on Power3 Medical Products (OTCBB: PWRM), the developer
of several blood tests designed for early detection, monitoring and targeting of
diseases like Alzheimer's, Parkinson's and breast cancer.

With 10 years of development of their technology and intellectual property, and
with commercialization in sight, Power3 is at a critical point in the company's
growth. Company CEO, Helen Park told BioMedReports on Tuesday afternoon:

"Power3 Medical Products has recently completed the Phase I Clinical Trials for
Alzheimer's and Parkinson's diseases blood diagnostic tests with better than
expected results and launched the Phase II clinical trials for both of these
diseases. Our Chief Scientific Officer, Dr. Ira Goldknopf, is reporting new
information on these results at the BIT meeting in China this week."

The medical community's interest in these new tests, huge market potential,
pending positive news, partnerships and technical analysis here look very solid
and the stock will open on Wednesday roughly three cents away from potential
break-out over a previous level of resistance and previous high.

The complete report is available now at BioMedReports.com:


http://biomedreports.com/component/content/article/56-top-leading-news/18487-ready-to-run-power3-medical-products-otcpwrm.html

Biotech investors interested in accessing the news portal's complete database of
clinical trials and upcoming FDA decisions can access that information here:

http://biomedreports.com/fda-calendar/fda-calendar.html

About BioMedReports.com

BioMedReports.com is a news portal covering the biomedical news and financial
sector. BioMedReports is not paid, compensated or in any way incentivized to
report news and developments about publicly traded companies.

For more biomedical sector and investment news go to http://BioMedReports.com





Media Contact:

M. Davila

Assistant Editor

BioMedReports.com

e-mail: Email Contact

Tel: +1 323 472 4480

Fax: +1 888 210 3556





SOURCE: BioMedReports




CONTACT: http://www2.marketwire.com/mw/emailprcntct?id=83D42451FB0F4EC2




Copyright 2009 Marketwire, Inc., All rights reserved.

-0-




SUBJECT CODE: Medical and Healthcare:Healthcare

Pharmaceuticals and Biotech:Drugs

Pharmaceuticals and Biotech:Biotech

Source: Comtex Wall Street News